Windtree Therapeutics, Inc.

Windtree Therapeutics, Inc.

WINT
Windtree Therapeutics, Inc.US flagOther OTC
0.01
USD
+0.00
- -
471,923.00Market Cap

Windtree Therapeutics, Inc. (WINT) Stock Splits

Learn about Windtree Therapeutics, Inc.'s most recent 1-for-50 basis stock split on February 21, 2025. Understand the impact on shareholders and the company's market position.

Latest Stock Split Details

Key information about Windtree Therapeutics, Inc.'s most recent stock split

Split Date: 2025-02-21
Split Ratio: 1:50
Price Before Split: $0.09
Price After Split: $0.00

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 50.00 times fewer shares (a 1:50 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Windtree Therapeutics, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2025-02-211:50Yes$0.09$0.00
2024-04-221:18Yes$0.30$0.02
2023-02-241:50Yes$0.14$0.00
2020-04-291:3Yes$3.30$1.10
2017-12-221:20Yes$0.21$0.01
2016-01-221:14Yes$0.16$0.01
2010-12-281:15Yes$0.26$0.02
1997-12-011:3Yes$0.13$0.04

About Windtree Therapeutics, Inc.

Company overview and industry information

Windtree Therapeutics, Inc. (WINT) operates in the Biotechnology industry. The recent 1-for-50 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Windtree Therapeutics, Inc. Summary

Last updated: 6/4/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.